Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 329

1.

Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases.

Ter Haar NM, Eijkelboom C, Cantarini L, Papa R, Brogan PA, Kone-Paut I, Modesto C, Hofer M, Iagaru N, Fingerhutová S, Insalaco A, Licciardi F, Uziel Y, Jelusic M, Nikishina I, Nielsen S, Papadopoulou-Alataki E, Olivieri AN, Cimaz R, Susic G, Stanevica V, van Gijn M, Vitale A, Ruperto N, Frenkel J, Gattorno M; Eurofever registry and the Pediatric Rheumatology International Trial Organization (PRINTO).

Ann Rheum Dis. 2019 Jul 5. pii: annrheumdis-2018-214472. doi: 10.1136/annrheumdis-2018-214472. [Epub ahead of print]

PMID:
31278138
2.

The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis.

Giani T, De Masi S, Maccora I, Tirelli F, Simonini G, Falconi M, Cimaz R.

Front Pharmacol. 2019 Jun 12;10:637. doi: 10.3389/fphar.2019.00637. eCollection 2019.

3.

The protease systems and their pathogenic role in juvenile idiopathic arthritis.

Margheri F, Laurenzana A, Giani T, Maggi L, Cosmi L, Annunziato F, Cimaz R, Del Rosso M.

Autoimmun Rev. 2019 Jun 8. pii: S1568-9972(19)30137-5. doi: 10.1016/j.autrev.2019.06.010. [Epub ahead of print] Review.

PMID:
31181328
4.

Kawasaki disease triggered by parvovirus infection: an atypical case report of two siblings.

Maggio MC, Cimaz R, Alaimo A, Comparato C, Di Lisi D, Corsello G.

J Med Case Rep. 2019 Apr 24;13(1):104. doi: 10.1186/s13256-019-2028-5.

5.

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.

Bettiol A, Lopalco G, Emmi G, Cantarini L, Urban ML, Vitale A, Denora N, Lopalco A, Cutrignelli A, Lopedota A, Venerito V, Fornaro M, Vannacci A, Rigante D, Cimaz R, Iannone F.

Int J Mol Sci. 2019 Apr 17;20(8). pii: E1898. doi: 10.3390/ijms20081898. Review.

6.

Extensive Ethnic Variation and Linkage Disequilibrium at the FCGR2/3 Locus: Different Genetic Associations Revealed in Kawasaki Disease.

Nagelkerke SQ, Tacke CE, Breunis WB, Tanck MWT, Geissler J, Png E, Hoang LT, van der Heijden J, Naim ANM, Yeung RSM, Levin ML, Wright VJ, Burgner DP, Ponsonby AL, Ellis JA, Cimaz R, Shimizu C, Burns JC, Fijnvandraat K, van der Schoot CE, van den Berg TK, de Boer M, Davila S, Hibberd ML, Kuijpers TW; International Kawasaki Disease Genetics Consortium.

Front Immunol. 2019 Mar 21;10:185. doi: 10.3389/fimmu.2019.00185. eCollection 2019.

7.

Th17 and Th1 Lymphocytes in Oligoarticular Juvenile Idiopathic Arthritis.

Maggi L, Mazzoni A, Cimaz R, Liotta F, Annunziato F, Cosmi L.

Front Immunol. 2019 Mar 14;10:450. doi: 10.3389/fimmu.2019.00450. eCollection 2019. Review.

8.

First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry).

Fredi M, Andreoli L, Bacco B, Bertero T, Bortoluzzi A, Breda S, Cappa V, Ceccarelli F, Cimaz R, De Vita S, Di Poi E, Elefante E, Franceschini F, Gerosa M, Govoni M, Hoxha A, Lojacono A, Marozio L, Mathieu A, Meroni PL, Minniti A, Mosca M, Muscarà M, Padovan M, Piga M, Priori R, Ramoni V, Ruffatti A, Tani C, Tonello M, Trespidi L, Zatti S, Calza S, Tincani A, Brucato A.

Front Cardiovasc Med. 2019 Feb 28;6:11. doi: 10.3389/fcvm.2019.00011. eCollection 2019.

9.

Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used?

Jelusic M, Sestan M, Cimaz R, Ozen S.

Pediatr Rheumatol Online J. 2019 Feb 28;17(1):10. doi: 10.1186/s12969-019-0311-z. Review.

10.

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis.

Sota J, Insalaco A, Cimaz R, Alessio M, Cattalini M, Gallizzi R, Maggio MC, Lopalco G, La Torre F, Fabiani C, Pardeo M, Olivieri AN, Sfriso P, Salvarani C, Gaggiano C, Grosso S, Bracaglia C, De Benedetti F, Rigante D, Cantarini L.

Front Pharmacol. 2019 Jan 8;9:1526. doi: 10.3389/fphar.2018.01526. eCollection 2018.

11.

Clinical Use and Molecular Action of Corticosteroids in the Pediatric Age.

Ferrara G, Petrillo MG, Giani T, Marrani E, Filippeschi C, Oranges T, Simonini G, Cimaz R.

Int J Mol Sci. 2019 Jan 21;20(2). pii: E444. doi: 10.3390/ijms20020444. Review.

12.

Gut microbiota in children and altered profiles in juvenile idiopathic arthritis.

De Filippo C, Di Paola M, Giani T, Tirelli F, Cimaz R.

J Autoimmun. 2019 Mar;98:1-12. doi: 10.1016/j.jaut.2019.01.001. Epub 2019 Jan 9. Review.

13.

How Should We Classify Kawasaki Disease?

Marrani E, Burns JC, Cimaz R.

Front Immunol. 2018 Dec 14;9:2974. doi: 10.3389/fimmu.2018.02974. eCollection 2018. Review.

14.

Detection of anti-adalimumab antibodies in a RA responsive cohort of patients using three different techniques.

Real-Fernández F, Pregnolato F, Cimaz R, Papini AM, Borghi MO, Meroni PL, Rovero P.

Anal Biochem. 2019 Feb 1;566:133-138. doi: 10.1016/j.ab.2018.11.018. Epub 2018 Nov 22.

PMID:
30471243
15.

Risks associated with use of TNF inhibitors in children with rheumatic diseases.

Marino A, Giani T, Cimaz R.

Expert Rev Clin Immunol. 2019 Feb;15(2):189-198. doi: 10.1080/1744666X.2019.1550359. Epub 2018 Nov 30.

PMID:
30451548
16.

Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments.

Marino A, Stagi S, Simonini G, Carli N, Caparello MC, Giani T, Pagnini I, De Masi S, Cimaz R.

Clin Exp Rheumatol. 2018 Sep-Oct;36(5):929-933. Epub 2018 Jul 19.

PMID:
30148444
17.

A misleading case of deficiency of adenosine deaminase 2 (DADA2): the magnifying glass of the scientific knowledge drives the tailored medicine in real life.

Maccora I, Frongia I, Azzari C, Ricci S, Cimaz R, Simonini G.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):146. Epub 2018 Jul 19. No abstract available.

18.

Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation.

Mazzoni A, Maggi L, Siracusa F, Ramazzotti M, Rossi MC, Santarlasci V, Montaini G, Capone M, Rossettini B, De Palma R, Kruglov A, Chang HD, Cimaz R, Maggi E, Romagnani S, Liotta F, Cosmi L, Annunziato F.

Eur J Immunol. 2019 Jan;49(1):79-95. doi: 10.1002/eji.201847677. Epub 2018 Nov 22.

PMID:
30144030
19.

Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting.

Ferrara G, Mastrangelo G, Barone P, La Torre F, Martino S, Pappagallo G, Ravelli A, Taddio A, Zulian F, Cimaz R; Rheumatology Italian Study Group.

Pediatr Rheumatol Online J. 2018 Jul 11;16(1):46. doi: 10.1186/s12969-018-0255-8. Review.

20.

Common symptoms for a rare disease in a girl with sarcoidosis: a case report.

Giovannini M, Luzzati M, Ferrara G, Buccoliero AM, Simonini G, de Martino M, Cimaz R, Giani T.

Ital J Pediatr. 2018 Jun 28;44(1):74. doi: 10.1186/s13052-018-0517-6.

21.

The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series.

Kone-Paut I, Cimaz R, Herberg J, Bates O, Carbasse A, Saulnier JP, Maggio MC, Anton J, Piram M.

Autoimmun Rev. 2018 Aug;17(8):768-774. doi: 10.1016/j.autrev.2018.01.024. Epub 2018 Jun 6.

22.

Correction to: The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Consolaro A, Bovis F, Pistorio A, Cimaz R, De Benedetti F, Miniaci A, Corona F, Gerloni V, Martino S, Pastore S, Barone P, Pieropan S, Cortis E, Podda RA, Gallizzi R, Civino A, La Torre F, Rigante D, Consolini R, Maggio MC, Magni-Manzoni S, Perfetti F, Filocamo G, Toppino C, Licciardi F, Garrone M, Scala S, Patrone E, Tonelli M, Tani D, Ravelli A, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Jul;38(7):1311-1313. doi: 10.1007/s00296-018-4042-0.

PMID:
29786780
23.

Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study.

Sota J, Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Gentileschi S, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Angotti R, Messina M, Tosi GM, Rigante D, Cantarini L; “Working Group” of Systemic Autoinflammatory Diseases of SIR (Italian Society of Rheumatology).

Clin Rheumatol. 2018 Aug;37(8):2233-2240. doi: 10.1007/s10067-018-4119-x. Epub 2018 May 17.

PMID:
29770930
24.

How advances in personalized medicine will change rheumatology.

Selmi C, Kon E, De Santis M, Favalli EG, Cimaz R, Generali E, Sinigaglia L.

Per Med. 2018 Mar;15(2):75-78. doi: 10.2217/pme-2017-0079. Epub 2018 Feb 2. No abstract available.

PMID:
29714121
25.

Correction to: A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry.

Gallizzi R, Pidone C, Cantarini L, Finetti M, Cattalini M, Filocamo G, Insalaco A, Rigante D, Consolini R, Maggio MC, Civino A, Martino S, Olivieri AN, Fabio G, Pastore S, Mauro A, Sutera D, Trimarchi G, Ruperto N, Gattorno M, Cimaz R; for EUROFEVER and the Paediatric Rheumatology International Trials Organisation (PRINTO).

Pediatr Rheumatol Online J. 2018 Apr 23;16(1):29. doi: 10.1186/s12969-018-0241-1.

26.

Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach.

Marrani E, Foeldvari I, Lopez JA, Cimaz R, Simonini G.

Semin Arthritis Rheum. 2018 Dec;48(3):495-503. doi: 10.1016/j.semarthrit.2018.03.003. Epub 2018 Mar 14.

PMID:
29655520
27.

Treating juvenile idiopathic arthritis to target: recommendations of an international task force.

Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, Al-Mayouf SM, Antón J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, De Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalhães C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS.

Ann Rheum Dis. 2018 Jun;77(6):819-828. doi: 10.1136/annrheumdis-2018-213030. Epub 2018 Apr 11.

PMID:
29643108
28.

The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).

Consolaro A, Bovis F, Pistorio A, Cimaz R, De Benedetti F, Miniaci A, Corona F, Gerloni V, Martino S, Pastore S, Barone P, Pieropan S, Cortis E, Podda RA, Gallizzi R, Civino A, Torre F, Rigante D, Consolini R, Maggio MC, Magni-Manzoni S, Perfetti F, Filocamo G, Toppino C, Licciardi F, Garrone M, Scala S, Patrone E, Tonelli M, Tani D, Ravelli A, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO).

Rheumatol Int. 2018 Apr;38(Suppl 1):251-258. doi: 10.1007/s00296-018-3960-1. Epub 2018 Apr 7. Erratum in: Rheumatol Int. 2018 May 21;:.

29.

S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome.

Wang L, Rosé CD, Foley KP, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Fernández-Martín J, Guly C, Hachulla E, Harjacek M, Mackensen F, Merino R, Modesto C, Naranjo Hernández A, Pajot C, Ramanan AV, Thatayatikom A, Thomée C, Vastert S, Votta BJ, Bertin J, Wouters CH.

Rheumatology (Oxford). 2018 Apr 7. doi: 10.1093/rheumatology/key090. [Epub ahead of print]

PMID:
29635517
30.

Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations.

Marino A, Real-Fernández F, Rovero P, Giani T, Pagnini I, Cimaz R, Simonini G.

Clin Rheumatol. 2018 May;37(5):1407-1411. doi: 10.1007/s10067-018-4057-7. Epub 2018 Mar 5.

PMID:
29508177
31.

Inflammatory morphea presenting as a hemifacial acquired port-wine stain.

Bassi A, Piccini P, Filippeschi C, Oranges T, Giani T, Neri I, Cimaz R, Martino M.

Arch Dis Child. 2019 Mar;104(3):296. doi: 10.1136/archdischild-2017-314721. Epub 2018 Feb 15. No abstract available.

PMID:
29449213
32.

Baseline ultrasound examination as possible predictor of relapse in patients affected by juvenile idiopathic arthritis (JIA).

De Lucia O, Ravagnani V, Pregnolato F, Hila A, Pontikaki I, Gattinara M, Romano M, Gerloni V, Pieropan S, Murgo A, Rossini M, Cimaz R, Meroni PL.

Ann Rheum Dis. 2018 Oct;77(10):1426-1431. doi: 10.1136/annrheumdis-2017-211696. Epub 2018 Feb 6.

PMID:
29437586
33.

A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry.

Gallizzi R, Pidone C, Cantarini L, Finetti M, Cattalini M, Filocamo G, Insalaco A, Rigante D, Consolini R, Maggio MC, Civino A, Martino S, Olivieri AN, Fabio G, Pastore S, Mauro A, Sutera D, Trimarchi G, Ruperto N, Gattorno M, Cimaz R.

Pediatr Rheumatol Online J. 2017 Dec 21;15(1):84. doi: 10.1186/s12969-017-0213-x. Erratum in: Pediatr Rheumatol Online J. 2018 Apr 23;16(1):29.

34.

Joint pain management in children and adolescents.

Marrani E, Maccora I, Giani T, Simonini G, Cimaz R.

Minerva Pediatr. 2018 Feb;70(1):79-97. doi: 10.23736/S0026-4946.17.05137-4. Epub 2017 Nov 21. Review.

PMID:
29160644
35.

Association of Natural Killer Cell Ligand Polymorphism HLA-C Asn80Lys With the Development of Anti-SSA/Ro-Associated Congenital Heart Block.

Ainsworth HC, Marion MC, Bertero T, Brucato A, Cimaz R, Costedoat-Chalumeau N, Fredi M, Gaffney P, Kelly J, Levesque K, Maltret A, Morel N, Ramoni V, Ruffatti A, Langefeld CD, Buyon JP, Clancy RM.

Arthritis Rheumatol. 2017 Nov;69(11):2170-2174. doi: 10.1002/art.40228. Epub 2017 Oct 17.

36.

Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.

Jamilloux Y, Lefeuvre L, Magnotti F, Martin A, Benezech S, Allatif O, Penel-Page M, Hentgen V, Sève P, Gerfaud-Valentin M, Duquesne A, Desjonquères M, Laurent A, Rémy-Piccolo V, Cimaz R, Cantarini L, Bourdonnay E, Walzer T, Py BF, Belot A, Henry T.

Rheumatology (Oxford). 2018 Jan 1;57(1):100-111. doi: 10.1093/rheumatology/kex373.

PMID:
29040788
37.

2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects.

Rider LG, Ruperto N, Pistorio A, Erman B, Bayat N, Lachenbruch PA, Rockette H, Feldman BM, Huber AM, Hansen P, Oddis CV, Lundberg IE, Amato AA, Chinoy H, Cooper RG, Chung L, Danko K, Fiorentino D, García-De la Torre I, Reed AM, Wook Song Y, Cimaz R, Cuttica RJ, Pilkington CA, Martini A, van der Net J, Maillard S, Miller FW, Vencovsky J, Aggarwal R; International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation.

Rheumatology (Oxford). 2017 Nov 1;56(11):1884-1893. doi: 10.1093/rheumatology/kex226.

38.

Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration.

Simonini G, Ferrara G, Pontikaki I, Scoccimarro E, Giani T, Taddio A, Meroni PL, Cimaz R.

Arthritis Care Res (Hoboken). 2018 Jul;70(7):1046-1051. doi: 10.1002/acr.23435. Epub 2018 Apr 24.

39.

Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series.

Sarens IL, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Dick AD, Espada G, Fernandez-Martin J, Guly CM, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Modesto C, Naranjo A, Oliveira-Knupp S, Özen S, Pajot C, Ramanan AV, Russo R, Susic G, Thatayatikom A, Thomée C, Vastert S, Bertin J, Arostegui JI, Rose CD, Wouters CH.

Am J Ophthalmol. 2018 Mar;187:158-166. doi: 10.1016/j.ajo.2017.08.017. Epub 2017 Sep 6.

PMID:
28887115
40.

Sex Differences in Pediatric Rheumatology.

Cattalini M, Soliani M, Caparello MC, Cimaz R.

Clin Rev Allergy Immunol. 2019 Jun;56(3):293-307. doi: 10.1007/s12016-017-8642-3. Review.

PMID:
28849549
41.

Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: two case reports.

Maggio MC, Mastrangelo G, Skabar A, Ventura A, Carrozzi M, Santangelo G, Vanadia F, Corsello G, Cimaz R.

J Med Case Rep. 2017 Aug 16;11(1):225. doi: 10.1186/s13256-017-1388-y.

42.

Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.

Westwell-Roper C, Lubieniecka JM, Brown KL, Morishita KA, Mammen C, Wagner-Weiner L, Yen E, Li SC, O'Neil KM, Lapidus SK, Brogan P, Cimaz R, Cabral DA; for ARChiVe Investigators Network within the PedVas initiative.

Pediatr Rheumatol Online J. 2017 Aug 7;15(1):61. doi: 10.1186/s12969-017-0191-z.

43.

How I treat juvenile idiopathic arthritis: A state of the art review.

Cimaz R, Marino A, Martini A.

Autoimmun Rev. 2017 Oct;16(10):1008-1015. doi: 10.1016/j.autrev.2017.07.014. Epub 2017 Aug 1. Review.

PMID:
28778702
44.

Physical Exercise and Physical Activity for Children and Adolescents With Juvenile Idiopathic Arthritis: A Literature Review.

Catania H, Fortini V, Cimaz R.

Pediatr Phys Ther. 2017 Jul;29(3):256-260. doi: 10.1097/PEP.0000000000000436. Review.

PMID:
28654499
45.

Musculin inhibits human T-helper 17 cell response to interleukin 2 by controlling STAT5B activity.

Santarlasci V, Mazzoni A, Capone M, Rossi MC, Maggi L, Montaini G, Rossettini B, Cimaz R, Ramazzotti M, Barra G, De Palma R, Maggi E, Liotta F, Cosmi L, Romagnani S, Annunziato F.

Eur J Immunol. 2017 Sep;47(9):1427-1442. doi: 10.1002/eji.201746996. Epub 2017 Jul 6.

46.

Epidemiology of Kawasaki disease in Italy: surveillance from national hospitalization records.

Cimaz R, Fanti E, Mauro A, Voller F, Rusconi F.

Eur J Pediatr. 2017 Aug;176(8):1061-1065. doi: 10.1007/s00431-017-2947-3. Epub 2017 Jun 14.

PMID:
28612175
47.

Osteoporosis in childhood.

Vierucci F, Saggese G, Cimaz R.

Curr Opin Rheumatol. 2017 Sep;29(5):535-546. doi: 10.1097/BOR.0000000000000423. Review.

PMID:
28582319
48.

Canakinumab for the treatment of TNF-receptor associated periodic syndrome.

La Torre F, Caparello MC, Cimaz R.

Expert Rev Clin Immunol. 2017 Jun;13(6):513-523. doi: 10.1080/1744666X.2017.1324783. Review.

PMID:
28454496
49.

An Update on the Pathogenesis and Treatment of Chronic Recurrent Multifocal Osteomyelitis in Children.

Taddio A, Zennaro F, Pastore S, Cimaz R.

Paediatr Drugs. 2017 Jun;19(3):165-172. doi: 10.1007/s40272-017-0226-4. Review.

PMID:
28401420
50.

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.

Rider LG, Aggarwal R, Pistorio A, Bayat N, Erman B, Feldman BM, Huber AM, Cimaz R, Cuttica RJ, de Oliveira SK, Lindsley CB, Pilkington CA, Punaro M, Ravelli A, Reed AM, Rouster-Stevens K, van Royen-Kerkhof A, Dressler F, Saad Magalhaes C, Constantin T, Davidson JE, Magnusson B, Russo R, Villa L, Rinaldi M, Rockette H, Lachenbruch PA, Miller FW, Vencovsky J, Ruperto N; International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation.

Ann Rheum Dis. 2017 May;76(5):782-791. doi: 10.1136/annrheumdis-2017-211401. Erratum in: Ann Rheum Dis. 2018 Apr;77(4):623.

Supplemental Content

Support Center